Indian scientists have developed a new gene editing (GE) technology using TnpB proteins as an alternative to CRISPR-Cas.
The Indian Council of Agricultural Research (ICAR) received a patent for this TnpB-based GE technology on September 15, 2025.
TnpB proteins are smaller than Cas9 and Cas12a proteins, making them easier to deliver into cells.
This indigenous technology aims to facilitate cheaper and more accessible GE crop breeding without intellectual property (IP) restrictions.
In May 2025, ICAR announced the release of two GE rice varieties.
Detailed Insights:
The CRISPR-Cas technology is primarily controlled by the Broad Institute and Corteva Agriscience, potentially hindering commercial cultivation due to IP rights and licensing fees.
TnpB proteins, with only 400-500 amino acids, are significantly smaller compared to Cas9 (1,000-1,400 amino acids) and Cas12a (around 1,300 amino acids), simplifying their delivery into cells.
GE involves editing genes naturally present in the host plant without introducing foreign genes, differing from genetic modification (GM).
The TnpB-based GE system includes both the TnpB protein (molecular scissors) and a guide RNA to target specific DNA locations.
ICAR is negotiating with Corteva and Broad Institute for waivers on license fees for small and marginal farmers regarding the commercial planting of GE varieties.
Key Concepts Involved:
Genome Editing (GE): Precisely modifying the DNA sequence of an organism.
CRISPR-Cas: A gene editing technology that uses Cas proteins to cleave DNA.
Intellectual Property (IP): Rights protecting inventions, potentially restricting the use of certain technologies.